U.S. Dental Membrane And Bone Graft Substitutes Market Size, Share & Trends Analysis Report By Product, By Application, And Segment Forecasts, 2025 - 2033

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Application
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity price analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product Outlook
  • 2.2.2. Application Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Dental Membrane And Bone Graft Substitutes Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising burden of dental disorders
    • 3.2.1.2. Development of synthetic bone grafts
    • 3.2.1.3. Growing demand for aesthetic and restorative dental procedures
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of dental treatments
    • 3.2.2.2. Potential risks and complications associated with dental procedures
  • 3.2.3. Market Challenge Analysis
    • 3.2.3.1. Regulatory and approval complexities
    • 3.2.3.2. Economic and currency exchange risks
  • 3.2.4. Market Opportunity Analysis
    • 3.2.4.1. Increasing number of clinical trials
    • 3.2.4.2. Growing development & approvals of resorbable membranes
    • 3.2.4.3. Expansion into synthetic membrane
    • 3.2.4.4. Strategic partnerships & investment to enhance market presence
    • 3.2.4.5. Expansion opportunities in emerging economies
    • 3.2.4.6. Increasing demand for composite bone grafts
    • 3.2.4.7. Growing focus on 3D printed and custom grafts
• 3.3. U.S. Dental Membrane And Bone Graft Substitutes Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. U.S. Dental Membrane And Bone Graft Substitutes Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Dental Membrane And Bone Graft Substitutes Market Product Movement Analysis
• 4.3. U.S. Dental Membrane And Bone Graft Substitutes Market Size & Trend Analysis, by Product 2021 to 2033 (USD Million)
• 4.4. Bone Graft Substitutes (BGS)
  • 4.4.1. Bone graft substitutes (BGS) market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.1.1. Allograft
      • 4.4.1.1.1. Allograft market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.4.1.1.1.1. Demineralized Bone Matrix
          • 4.4.1.1.1.1.1. Demineralized bone matrix market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.4.1.1.1.2. Others
          • 4.4.1.1.1.2.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.1.2. Autograft
      • 4.4.1.2.1. Autograft market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.1.3. Xenograft
      • 4.4.1.3.1. Xenograft market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.4.1.3.1.1. Bovine Derived
          • 4.4.1.3.1.1.1. Bovine derived market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.4.1.3.1.2. Porcine Derived
          • 4.4.1.3.1.2.1. Porcine derived market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.4.1.3.1.3. Others
          • 4.4.1.3.1.3.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.1.4. Synthetic
      • 4.4.1.4.1. Synthetic market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.4.1.4.1.1. Hydroxyapatite (HA)
          • 4.4.1.4.1.1.1. Hydroxyapatite (HA) market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.4.1.4.1.2. Tricalcium Phosphate (TCP)
          • 4.4.1.4.1.2.1. Tricalcium phosphate (TCP) market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.4.1.4.1.3. Bioactive Glass
          • 4.4.1.4.1.3.1. Bioactive glass market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.4.1.4.1.4. Others
          • 4.4.1.4.1.4.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.5. Dental Membranes and Soft Tissue Regeneration Materials
  • 4.5.1. Dental membranes and soft tissue regeneration materials market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.5.1.1. Resorbable membranes
      • 4.5.1.1.1. Resorbable membranes market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.5.1.1.1.1. Bovine -derived collagen based
          • 4.5.1.1.1.1.1. Bovine -derived collagen based market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.5.1.1.1.2. Porcine derived collagen based
          • 4.5.1.1.1.2.1. Porcine derived collagen based market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.5.1.1.1.3. Others
          • 4.5.1.1.1.3.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.5.1.2. Non resorbable membranes
      • 4.5.1.2.1. Non resorbable membranes market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.5.1.2.1.1. Expanded PTFE (ePTFE)
          • 4.5.1.2.1.1.1. Expanded PTFE (ePTFE) market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.5.1.2.1.2. Dense PTFE (dPTFE)
          • 4.5.1.2.1.2.1. Dense PTFE (dPTFE) market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.5.1.2.1.3. Titanium-Reinforced PTFE
          • 4.5.1.2.1.3.1. Titanium-reinforced PTFE market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 5. U.S. Dental Membrane And Bone Graft Substitutes Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Dental Membrane And Bone Graft Substitutes Market Application Movement Analysis
• 5.3. U.S. Dental Membrane And Bone Graft Substitutes Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Ridge Augmentation
  • 5.4.1. Ridge augmentation market estimates and forecast 2021 to 2033 (USD Million)
• 5.5. Sinus Lift
  • 5.5.1. Sinus lift market estimates and forecast 2021 to 2033 (USD Million)
• 5.6. Periodontal Defect Regeneration
  • 5.6.1. Periodontal defect regeneration market estimates and forecast 2021 to 2033 (USD Million)
• 5.7. Implant Bone Regeneration
  • 5.7.1. Implant bone regeneration market estimates and forecast 2021 to 2033 (USD Million)
• 5.8. Socket Preservation
  • 5.8.1. Socket preservation market estimates and forecasts for 2021 to 2033 (USD Million)
• 5.9. Soft Tissue Regeneration
  • 5.9.1. Soft tissue regeneration market estimates and forecast 2021 to 2033 (USD Million)
• 5.10. Others
  • 5.10.1. Others market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company/Competition Categorization
  • 6.2.1. Innovators
• 6.3. Vendor Landscape
  • 6.3.1. Key company market share analysis, 2024
  • 6.3.2. Dentsply Sirona
    • 6.3.2.1. Company overview
    • 6.3.2.2. Financial performance
    • 6.3.2.3. Usage benchmarking
    • 6.3.2.4. Strategic initiatives
  • 6.3.3. Bioteck S.p.A.
    • 6.3.3.1. Company overview
    • 6.3.3.2. Financial performance
    • 6.3.3.3. Usage benchmarking
    • 6.3.3.4. Strategic initiatives
  • 6.3.4. Institut Straumann AG
    • 6.3.4.1. Company overview
    • 6.3.4.2. Financial performance
    • 6.3.4.3. Usage benchmarking
    • 6.3.4.4. Strategic initiatives
  • 6.3.5. Maxigen Biotech Inc.
    • 6.3.5.1. Company overview
    • 6.3.5.2. Financial performance
    • 6.3.5.3. Usage benchmarking
    • 6.3.5.4. Strategic initiatives
  • 6.3.6. Nobel Biocare Services AG (Envista)
    • 6.3.6.1. Company overview
    • 6.3.6.2. Financial performance
    • 6.3.6.3. Usage benchmarking
    • 6.3.6.4. Strategic initiatives
  • 6.3.7. Geistlich Pharma North America, Inc.
    • 6.3.7.1. Company overview
    • 6.3.7.2. Financial performance
    • 6.3.7.3. Usage benchmarking
    • 6.3.7.4. Strategic initiatives
  • 6.3.8. ZimVie Inc.
    • 6.3.8.1. Company overview
    • 6.3.8.2. Financial performance
    • 6.3.8.3. Usage benchmarking
    • 6.3.8.4. Strategic initiatives
  • 6.3.9. NovaBone (Halma)
    • 6.3.9.1. Company overview
    • 6.3.9.2. Financial performance
    • 6.3.9.3. Usage benchmarking
    • 6.3.9.4. Strategic initiatives
  • 6.3.10. Regenity
    • 6.3.10.1. Company overview
    • 6.3.10.2. Financial performance
    • 6.3.10.3. Usage benchmarking
    • 6.3.10.4. Strategic initiatives
  • 6.3.11. Medtronic
    • 6.3.11.1. Company overview
    • 6.3.11.2. Financial performance
    • 6.3.11.3. Usage benchmarking
    • 6.3.11.4. Strategic initiatives
  • 6.3.12. BioHorizons
    • 6.3.12.1. Company overview
    • 6.3.12.2. Financial performance
    • 6.3.12.3. Usage benchmarking
    • 6.3.12.4. Strategic initiatives
  • 6.3.13. Curasan, Inc.
    • 6.3.13.1. Company overview
    • 6.3.13.2. Financial performance
    • 6.3.13.3. Usage benchmarking
    • 6.3.13.4. Strategic initiatives
  • 6.3.14. DentiumUSA
    • 6.3.14.1. Company overview
    • 6.3.14.2. Financial performance
    • 6.3.14.3. Usage benchmarking
    • 6.3.14.4. Strategic initiatives
  • 6.3.15. Unicare Biomedical, Inc.
    • 6.3.15.1. Company overview
    • 6.3.15.2. Financial performance
    • 6.3.15.3. Usage benchmarking
    • 6.3.15.4. Strategic initiatives
  • 6.3.16. Neoss
    • 6.3.16.1. Company overview
    • 6.3.16.2. Financial performance
    • 6.3.16.3. Usage benchmarking
    • 6.3.16.4. Strategic initiatives

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 U.S. dental membrane and bone graft substitutes market, by country, 2021 - 2033 (USD Million)
• Table 4 U.S. dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
• Table 5 U.S. dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 U.S. Dental Membrane And Bone Graft Substitutes Market, Market Segmentation
• Fig. 7 Market Driver Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Analysis (Current & Future Impact)
• Fig. 9 Market Opportunity Analysis (Current & Future Impact)
• Fig. 10 Market Challenge Analysis (Current & Future Impact)
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 Dental membrane and bone graft substitutes market: Product movement analysis
• Fig. 14 Bone Graft Substitutes (BGS) Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 15 Allograft Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 16 Demineralized Bone Matrix Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 17 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 18 Autograft Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 19 Xenograft Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 20 Bovine Derived Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 21 Porcine Derived Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 22 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 23 Synthetic Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 24 Hydroxyapatite (HA) Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 25 Tricalcium Phosphate (TCP) Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 26 Bioactive Glass Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 27 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 28 Dental Membranes and Soft Tissue Regeneration Materials Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 29 Resorbable Membranes Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 30 Bovine -Derived Collagen Based Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 31 Porcine Derived Collagen Based Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 32 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 33 Non Resobable Membranes Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 34 Expanded PTFE (ePTFE) Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 35 Dense PTFE (dPTFE) Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 36 Titanium-Reinforced PTFE Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 37 Dental Membrane And Bone Graft Substitutes Market: Application Movement Analysis
• Fig. 38 Ridge Augmentation Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 39 Sinus Lift Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 40 Periodontal Defect Regeneration Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 41 Implant Bone Regeneration Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 42 Socket Preservation Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 43 Soft Tissue Regeneration Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 44 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)